List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
This medicine has the best evidence for effectiveness and safety. |
Costa Rica. Caja Costarricense de Seguro Social. 2019 | 12. Hemostáticos |
Others observations: Polvo liofilizado para solución inyectable. Frasco con diluyente x 5 mL. |
Cuba. Cuadro Básico de Medicamentos 2018. Ministerio de Salud Pública. | CUADRO BÁSICO DE MEDICAMENTOS 2018. Ministerio de Salud Pública. |
Others observations: EST POR 1 BULBO |
Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
List | Section | Observation |
---|---|---|
WHO Model List of Essential Medicines (2021) | 11.2.2 Blood coagulation factors |
This medicine has the best evidence for effectiveness and safety. |
Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
List | Section | Observation |
---|---|---|
Barbados. Barbados National Drug Formulary (BNDF) | 20.28.16 Hemostatics | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
List | Section | Observation |
---|---|---|
Cayman Islands Health Services Authority Pharmacy Drug Formulary | 02.11 Antifibrinolytic Drugs and Haemostatics | No observations |
List | Section | Observation |
---|---|---|
Colombia. "Listado de Medicamentos del Plan de Beneficios en Salud con Cargo a la UPC" 2016 | Listado de Medicamentos del Plan de Beneficios en Salud con cargo a la UPC |
Others observations: INCLUYE TODAS LAS CONCENTRACIONES Y FORMAS FARMACÉUTICAS |
Jamaica. List of Vital Essential and Necessary Drugs and Medical Sundries for Public Health Institutions. 2015 | 01.04 HAEMOSTATICS |
Others observations: fraction |
Argentina. FTN COMRA. Confederacion Medica de la Rep. Argentina. 2018 | 08.02. FACTORES DE LA COAGULACION | No observations |
Suriname. NGK-C-011 | 11.2 Plasma fractions for specific use | No observations |
Suriname. NGK-C-011 | 29.2 Other Special Essential Medicines | No observations |
List | Section | Observation |
---|---|---|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |
List | Section | Observation |
---|---|---|
Brasil. Relação Nacional de Medicamentos Essenciais. 2020 | B. SANGUE E ÓRGÃOS HEMATOPOÉTICOS | No observations |
El Salvador - 2019 | ANTIHEMORRÁGICOS | No observations |
List | Section | Observation |
---|---|---|
Chile. Formulario Nacional de Medicamentos. 2005 | 10. PRODUCTOS SANGUINEOS Y SUCEDANEOS DEL PLASMA | No observations |
List | Section | Observation |
---|---|---|
Trinidad and Tobago. Pharmaceutical Ven Listing 2019. Ministry of Health. | Blood Hemostatics | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |
List | Section | Observation |
---|---|---|
Mexico. Cuadro Basico de Medicamentos - 2017 | 10. HEMATOLOGIA | No observations |